- Assistant Professor, CWRU School of Medicine
Erin Babbitt is a clinical neuropsychologist in the Division of Developmental and Behavioral Pediatrics and Psychology at University Hospitals Rainbow Babies & Children’s. She is an Assistant Professor of Pediatrics at Case Western Reserve University.
Dr. Babbitt is board certified in clinical neuropsychology through the American Board of Professional Psychology. She was named to the medical staff of UH Rainbow Babies & Children’s Hospital in 2015. Her special interests include neuropsychological assessment of the cognitive and behavioral outcomes of pediatric brain tumor and other cancers, prematurity, and a variety of neurological conditions like brain injury. Dr. Babbitt also specializes in assessing older children and adolescents for autism spectrum disorder and learning disabilities.
Her research interests include long term outcomes of children with neurological conditions and issues related to the transition to adulthood for children with medical and developmental disabilities, especially autism. Dr. Babbitt is a member of the National Academy of Neuropsychology, Ohio Psychological Association, and the American Academy of Clinical Neuropsychology.
- Behavioral Pediatrics
- Developmental Behavioral Pediatrics
- Pediatric Neuropsychology
RBC Rainbow Babies & Childrens
11100 Euclid Ave
Cleveland, OH 44106
DO 5850 Landerbrook
5850 Landerbrook Dr
Mayfield Heights, OH 44124
Fellowship | Neuropsychology
Neuropsychology - Uh Case Medical Center (2013 - 2015)
Internship | Neuropsychology
Neuropsychology - Phoenix Va Health Care System (2012 - 2013)
Arizona School Of Professional Psychology (2013)
Arizona State University (2004)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Erin Babbitt did not disclose any Outside Relationships with Industry.